Product Images Vardenafil Hydrochloride

This is a medication called Vardenafil Hydrochloride, which comes in a 2.5 mg dose and is dispensed with an attached patient information leaflet. It is indicated for oral consumption, and one tablet should be taken, no more than once per day. The medication should be stored in a container with a child-resistant closure at a controlled room temperature, and should be kept out of the reach of children. The medicine is manufactured in Israel by Teva Pharmaceutical Ind. Ltd for Teva Pharmaceuticals USA, Inc. It has a National Drug Code (NDC) of 0093-7652-56 and a Global Trade Item Number (GTIN) of 0300937652564.*

This is a medication information leaflet for a tablet containing vardenafil. The dosage instruction is to take one tablet as needed, once per day. There is a warning to keep the medication out of reach of children. The tablet was manufactured in Israel by Teva Pharmaceutical Industries Ltd and manufactured for Teva Pharmaceuticals USA, Inc. There is a GTIN code and lot number provided. The rest of the content is illegible.*

This is a medication information leaflet for hydrochloride tablets containing vardenafil, equivalent to 10 mg vardenafil HO. The recommended dosage is one tablet per day, with complete prescribing information provided. The medication should be stored at 20° to 25°C and dispensed in a tight container, out of the reach of children. It is manufactured in Israel by Teva Pharmaceutical Ind. Ltd for Teva Pharmaceuticals USA, Inc. This is a barcode-free area of the packaging.*

This text is a patient information leaflet for a medication called vardenafil hydrochloride, which comes in a package of 30 tablets. Each tablet contains 20mg of vardenafil and should be taken no more than once a day as needed. The complete prescribing information for dosage and administration is included in the package. The medication should be stored at a temperature between 20°C and 25°C and kept out of reach of children. The manufacturer is Teva Pharmaceutical Ind. Ltd. in Israel, and it was manufactured for Teva Pharmaceuticals USA, Inc. The text also includes some identifying numbers, such as NDC 0093-7655-56 and GTIN 0300937655565. There is a code in the text, 323K507830518, which is marked as non-varnish/coding area.*

The text contains a table or chart showing mean change (in mmHg) over time. The table has only one value, which is 15, and is not clear which variable is being measured. Therefore, it is not possible to provide a specific description of what the data represents.*

This appears to be a chart or graph showing the mean change in blood pressure in millimeters of mercury (mmHg) for two groups: one that received a placebo during stage 1, and another that received a drug called Varder. The chart shows that both groups had a mean change of around 10 mmHg (the vertical axis), but the timing of the placebo vs Varder treatment is unclear. Without more context, it is difficult to say what the significance of this chart is or what study it may come from.*